About Atmo Biosciences

Develops an ingestible gas-sensing capsule that measures gastrointestinal (GI) tract transit times and gas production by detecting temperature, hydrogen, carbon dioxide, and oxygen levels. This system provides clinicians with data to diagnose and evaluate motility disorders such as gastroparesis and slow transit constipation, improving the management of functional gut disorders affecting over 40% of the global population.

```xml <problem> Functional gastrointestinal disorders, affecting over 40% of the global population, are often challenging to diagnose due to the difficulty in directly measuring conditions within the GI tract. Current methods for evaluating motility disorders like gastroparesis and slow transit constipation lack a simple, direct way to measure regional gut transit times and gas production. This can lead to delayed diagnoses and ineffective management of these conditions. </problem> <solution> Atmo Biosciences offers the Atmo Gas Capsule System, an ingestible gas-sensing capsule that directly measures gases and other parameters throughout the gastrointestinal tract. The capsule wirelessly transmits data on temperature, hydrogen, carbon dioxide, and oxygen levels, along with indicators of capsule tumble and antenna reflectance. This data is then used to determine whole and regional gut transit times, aiding in the diagnosis and evaluation of motility disorders. The system provides clinicians with a simple, easy-to-use solution for gaining insights into gastrointestinal function, potentially improving the management of functional gut disorders. </solution> <features> - Ingestible capsule that directly measures gases at the source of production in the GI tract. - Measures whole gut and regional gut (stomach, small bowel, and colon) transit times. - Wireless data transmission of temperature, hydrogen concentration, carbon dioxide concentration, oxygen levels, capsule tumble, and antenna reflectance. - Data is uploaded to the cloud for aggregation, analysis, and patient reporting. - Potential applicability beyond diagnostic applications, useful for researchers to determine the impact and efficacy of dietary interventions. </features> <target_audience> The primary target audience includes gastroenterologists, healthcare professionals specializing in digestive disorders, and clinical researchers investigating gastrointestinal function and motility. </target_audience> ```

What does Atmo Biosciences do?

Where is Atmo Biosciences located?

Atmo Biosciences is based in Melbourne, Australia.

When was Atmo Biosciences founded?

Atmo Biosciences was founded in 2018.

Location

Melbourne, Australia

Founded

2018

Employees

32 employees

Major Investors

Medical Research Future Fund (MRFF)

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Atmo Biosciences

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

atmobiosciences.com 1K+

Crunchbase

Founded 2018 – Melbourne, Australia

Funding

Major Investors

Medical Research Future Fund (MRFF)

Team (30+)

No team information available.

Company Description

Problem

Functional gastrointestinal disorders, affecting over 40% of the global population, are often challenging to diagnose due to the difficulty in directly measuring conditions within the GI tract. Current methods for evaluating motility disorders like gastroparesis and slow transit constipation lack a simple, direct way to measure regional gut transit times and gas production. This can lead to delayed diagnoses and ineffective management of these conditions.

Solution

Atmo Biosciences offers the Atmo Gas Capsule System, an ingestible gas-sensing capsule that directly measures gases and other parameters throughout the gastrointestinal tract. The capsule wirelessly transmits data on temperature, hydrogen, carbon dioxide, and oxygen levels, along with indicators of capsule tumble and antenna reflectance. This data is then used to determine whole and regional gut transit times, aiding in the diagnosis and evaluation of motility disorders. The system provides clinicians with a simple, easy-to-use solution for gaining insights into gastrointestinal function, potentially improving the management of functional gut disorders.

Features

Ingestible capsule that directly measures gases at the source of production in the GI tract.

Measures whole gut and regional gut (stomach, small bowel, and colon) transit times.

Wireless data transmission of temperature, hydrogen concentration, carbon dioxide concentration, oxygen levels, capsule tumble, and antenna reflectance.

Data is uploaded to the cloud for aggregation, analysis, and patient reporting.

Potential applicability beyond diagnostic applications, useful for researchers to determine the impact and efficacy of dietary interventions.

Target Audience

The primary target audience includes gastroenterologists, healthcare professionals specializing in digestive disorders, and clinical researchers investigating gastrointestinal function and motility.